M Montini

1.5k total citations
30 papers, 821 citations indexed

About

M Montini is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, M Montini has authored 30 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in M Montini's work include Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (18 papers) and Adrenal and Paraganglionic Tumors (13 papers). M Montini is often cited by papers focused on Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (18 papers) and Adrenal and Paraganglionic Tumors (13 papers). M Montini collaborates with scholars based in Italy, Belgium and Australia. M Montini's co-authors include Renato Cozzi, G. Pagani, Roberto Attanasio, Giovanni Lasio, Mascia Albizzi, Sandro Lodrini, Alberto M Pedroncelli, Paola Doneda, M Barausse and D. Dallabonzana and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and European Journal of Endocrinology.

In The Last Decade

M Montini

28 papers receiving 797 citations

Peers

M Montini
Viktor Boerlin Switzerland
M Montini
Citations per year, relative to M Montini M Montini (= 1×) peers Viktor Boerlin

Countries citing papers authored by M Montini

Since Specialization
Citations

This map shows the geographic impact of M Montini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Montini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Montini more than expected).

Fields of papers citing papers by M Montini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Montini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Montini. The network helps show where M Montini may publish in the future.

Co-authorship network of co-authors of M Montini

This figure shows the co-authorship network connecting the top 25 collaborators of M Montini. A scholar is included among the top collaborators of M Montini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Montini. M Montini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pirchio, Rosa, et al.. (2023). Control of acromegaly in more than 90% of patients after 10 years of pegvisomant therapy: an European referral centre real-life experience. Journal of Endocrinological Investigation. 46(5). 1027–1038. 10 indexed citations
2.
Giustina, Andrea, Gherardo Mazziotti, Salvatore Cannavò, et al.. (2017). High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 102(7). 2454–2464. 44 indexed citations
3.
Seravalle, Gino, Roberto Attanasio, Guıdo Grassı, et al.. (2012). Decreased adrenergic tone in acromegaly: evidence from direct recording of muscle sympathetic nerve activity. Clinical Endocrinology. 77(2). 262–267. 6 indexed citations
4.
Mazziotti, Gherardo, Teresa Porcelli, Fausto Bogazzi, et al.. (2011). Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy. European Journal of Endocrinology. 164(3). 341–347. 42 indexed citations
5.
Giustina, Andrea, Stefania Bonadonna, Giovanna Bugari, et al.. (2009). High-dose octreotide LAR in patients with acromegaly inadequately controlled by conventional somatostatin analogue therapy: a randomized, controlled trial. Institutional Research Information System University of Ferrara (University of Ferrara). 1 indexed citations
6.
Cozzi, Renato, Giovanni Lasio, Andrea Cardia, et al.. (2009). Perioperative Cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas. Journal of Endocrinological Investigation. 32(5). 460–464. 32 indexed citations
7.
Giustina, Andrea, Stefania Bonadonna, Giovanna Bugari, et al.. (2009). High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. European Journal of Endocrinology. 161(2). 331–338. 101 indexed citations
8.
Attanasio, Roberto, Franco Grimaldi, Renato Cozzi, et al.. (2008). Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients. Journal of Endocrinological Investigation. 31(8). 704–710. 38 indexed citations
9.
Attanasio, Roberto, Roberto Lanzi, Marco Losa, et al.. (2008). Effects of Lanreotide Autogel on Growth Hormone,Insulinlike Growth Factor 1, and Tumor Size in Acromegaly: a 1-Year Prospective Multicenter Study. Endocrine Practice. 14(7). 846–855. 35 indexed citations
10.
Attanasio, Roberto, et al.. (2007). An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy. Pituitary. 11(1). 1–11. 12 indexed citations
11.
Cozzi, Renato, M Montini, Roberto Attanasio, et al.. (2006). Primary Treatment of Acromegaly with Octreotide LAR: A Long-Term (Up to Nine Years) Prospective Study of Its Efficacy in the Control of Disease Activity and Tumor Shrinkage. The Journal of Clinical Endocrinology & Metabolism. 91(4). 1397–1403. 166 indexed citations
12.
Cozzi, Renato, Roberto Attanasio, Silvia Grottoli, et al.. (2004). Treatment of acromegaly with SS analogues: Should GH and IGF-I target levels be lowered to assert a tight control of the disease?. Journal of Endocrinological Investigation. 27(11). 1040–1047. 15 indexed citations
13.
Cozzi, Renato, Roberto Attanasio, M Montini, et al.. (2003). Four-Year Treatment with Octreotide-Long-Acting Repeatable in 110 Acromegalic Patients: Predictive Value of Short-Term Results?. The Journal of Clinical Endocrinology & Metabolism. 88(7). 3090–3098. 153 indexed citations
14.
Verhelst, J., Roger Abs, M Montini, et al.. (2000). Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients. European Journal of Endocrinology. 143(5). 577–584. 53 indexed citations
15.
Agostinis, Cristina, et al.. (2000). “spontaneous” reduction of tonsillar herniation in acromegaly:. Surgical Neurology. 53(4). 396–399. 7 indexed citations
16.
Fisker, Sanne, et al.. (1997). Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR). European Journal of Endocrinology. 136(1). 61–66. 5 indexed citations
17.
Montini, M, Alberto M Pedroncelli, Roberto Caldara, et al.. (1994). Cholelithiasis and acromegaly: therapeutic strategies. Clinical Endocrinology. 40(3). 401–406. 31 indexed citations
18.
Pedroncelli, Alberto M, et al.. (1991). A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients. Gynecological Endocrinology. 5(3). 213–216. 3 indexed citations
19.
Pagani, G., et al.. (1991). Hypocalcemic effects of rectal and intramuscular administration of synthetic salmon calcitonin.. PubMed. 29(8). 329–32. 8 indexed citations
20.
Pagani, G., et al.. (1972). Effect of glipizide on a double-meal test in diabetic patients.. PubMed. 22(11). 1888–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026